Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia

OBJECTIVE: The aim of this analysis was to compare the effects of 2 atypical antipsychotic agents, lurasidone (80 mg/d or 160 mg/d) and quetiapine XR (600 mg/d), on daytime alertness, and to evaluate the effects of daytime sleepiness on treatment outcomes in patients with an acute exacerbation of sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Loebel, Antony D., Siu, Cynthia O., Cucchiaro, Josephine B., Pikalov, Andrei A., Harvey, Philip D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968912/
https://www.ncbi.nlm.nih.gov/pubmed/24330860
http://dx.doi.org/10.1017/S1092852913000904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968912/
https://www.ncbi.nlm.nih.gov/pubmed/24330860
http://dx.doi.org/10.1017/S1092852913000904

Ejemplares similares